Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.

Autor: Mariska C Vlot, Marlous L Grijsen, Jan M Prins, Renate T de Jongh, Robert de Jonge, Martin den Heijer, Annemieke C Heijboer

Publikováno v: PLoS ONE, Vol 13, Iss 3, p e0193679 (2018)

Previous studies indicate that human immunodeficiency virus (HIV)-infection and combination antiretroviral therapy (cART) can affect bone turnover. Furthermore, HIV-infected patients have lower bone mineral density (BMD) compared to a healthy referen

Externí odkaz: https://doaj.org/article/c70a89194c6b40c1b4a6e2be6c02b761

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty

Autor: Maria A T C van der Loos, Daniel T Klink, Martin den Heijer, Chantal M. Wiepjes, Mariska C. Vlot, Ilse Hellinga

Publikováno v: van der Loos, M A TC, Hellinga, I, Vlot, M C, Klink, D T, den Heijer, M & Wiepjes, C M 2021, ' Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty ', Journal of Bone and Mineral Research, vol. 36, no. 5, pp. 931-941 . https://doi.org/10.1002/jbmr.4262
Journal of Bone and Mineral Research, 36(5), 931-941. Wiley-Blackwell
Journal of Bone and Mineral Research

Bone geometry can be described in terms of periosteal and endocortical growth and is partly determined by sex steroids. Periosteal and endocortical apposition are thought to be regulated by testosterone and estrogen, respectively. Gender‐affirming

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a008e307a887ce79d2821ee8bcf2e6e8
https://doi.org/10.1002/jbmr.4262

Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen

Autor: Christel J.M. de Blok, Renate T. de Jongh, Chantal M Wiepjes, Jos W. R. Twisk, Mariska C. Vlot, Martin den Heijer, Paul Lips

Publikováno v: Bone and Mineral, 34(3), 447-454. Wiley-Blackwell
Wiepjes, C M, de Jongh, R T, de Blok, C J, Vlot, M C, Lips, P, Twisk, J W & den Heijer, M 2019, ' Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen ', Bone and Mineral, vol. 34, no. 3, pp. 447-454 . https://doi.org/10.1002/jbmr.3612
Journal of Bone and Mineral Research
Wiepjes, C M, de Jongh, R T, de Blok, C J M, Vlot, M C, Lips, P, Twisk, J W R & den Heijer, M 2019, ' Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen ', Journal of Bone and Mineral Research, vol. 34, no. 3, pp. 447-454 . https://doi.org/10.1002/jbmr.3612
Journal of Bone and Mineral Research, 34(3), 447-454. American Society for Bone and Mineral Research

Concerns about the effects of gender-affirming hormonal treatment (HT) on bone mineral density (BMD) in transgender people exist, particularly regarding the decrease in estrogen concentrations in transmen. Although it is known that HT is safe for BMD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3633dab4c1e42110d63700e9ff24a07c
https://doi.org/10.1002/jbmr.3612

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty

Autor: Maria A T C van der Loos, Daniel T Klink, Martin den Heijer, Chantal M. Wiepjes, Ilse Hellinga, Mariska C. Vlot

Publikováno v: Journal of the Endocrine Society

Bone geometry can be described in terms of periosteal and endocortical growth and is partly determined by sex steroids. Periosteal and endocortical apposition are thought to be regulated by testosterone and estrogen, respectively. Gender-affirming ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309fb26087abd4dca72509199deb3e07
http://europepmc.org/articles/PMC8265905

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)

Autor: Mariska C, Vlot, Laura, Boekel, Jolijn, Kragt, Joep, Killestein, Barbara M, van Amerongen, Robert, de Jonge, Martin, den Heijer, Annemieke C, Heijboer

Publikováno v: Nutrients

Vitamin D (VitD) insufficiency is common in multiple sclerosis (MS). VitD has possible anti-inflammatory effects on the immune system. The ratio between VitD metabolites in MS patients and the severity of the disease are suggested to be related. Howe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d20e026417f3f63b6e340575bea4f275
https://pubmed.ncbi.nlm.nih.gov/31731605